Drug Search Results
More Filters [+]

Lifibrol

Alternative Names: lifibrol
Latest Update: 2010-01-27
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: University Hospital, Bonn
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lifibrol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Hyperlipidemia|Hypercholesterolemia|Hyperlipoproteinemias

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

LIF293/95apoB

P3

Completed

Hyperlipidemia|Hypercholesterolemia|Hyperlipoproteinemias

1996-04-01

Recent News Events

Date

Type

Title